IASLC
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informat...
Be sure to visit the podcast's website and support the creator: www.iaslc.org
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
ELCC 2022 Highlights With Nicolas Girard And Lizza Hendriks 05.04.2022 26:31
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recently completed European Lung Cancer Congress. His guests include Dr. Lizza Hendriks, assistant professor at Maastricht University in the Netherlands. Dr. Hendriks is also a pulmonologist specializing in thoracic oncology and the program leader of the Innovative Cancer Diagnostics Therapy group at GROW School of Oncol...
Breakthrough Therapies NTRK With Robert Doebele 15.03.2022 32:59
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.
Targeted Therapies of Lung Cancer with Charu Aggarwal Lecia Sequist and Ivy Elkins 01.03.2022 48:52
The IASLC Targeted Therapies Meeting has historically been a very interactive, fast-paced meeting that highlights the latest and most innovative anticancer drugs, initially focused on targeted agents but in recent years, extending to immunotherapy. In this Lung Cancer Considered podcast hosts Dr. Narjust Duma and Dr. Stephen Liu lead a wide-ranging discussion of the meeting with three lung cancer...
NTRK with Herbert Ho Fung Loong 22.02.2022 26:39
Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the department of clinical oncology and deputy medical director of the Phase 1 Clinical Trials Center of The Chinese University of Hong Kong, joins Lung Cancer Considered host Dr. Stephen Liu to discuss...
ALK-Fusion Positive NSCLC With Jessica Jiyeong Lin And Ben Solomon 15.02.2022 46:00
Lung Cancer Considered hosts Dr. Narjust Duma and Dr. Stephen Liu discuss ALK-fusion positive NSCLC with Dr. Jessica Lin, a physician at the Massachusetts General Hospital Cancer Center and an Assistant Professor of Medicine at Harvard Medical School, and Dr. Ben Solomon, a professor and consultant medical oncologist at Peter MacCallum Cancer Center in Melbourne, Australia.
Breakthrough Therapies EGFR Mutant Lung Cancer with Zosia Piotrowska 01.02.2022 31:07
In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks with Dr. Zosia Piotrowska, Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital in Boston, Mass., about the current and future state of therapies for patients with EGFR mutant lung cancer.
Cell Therapy With Ben Creelan And Prasad Adusumilli 18.01.2022 37:28
Cell therapy has made strides in hematology and oncology and has recently shown promise in thoracic oncology. In this episode of Lung Cancer Considered host, Dr. Narjust Duma delves into this emerging therapy with guests Dr. Ben Creelan, associate professor of medicine at the University of South Florida, thoracic oncologist at Moffitt Cancer Center and Dr. Prasad Adusumilli, deputy chief and atten...
Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo 04.01.2022 44:14
This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cough, chest pain, and weight loss. Discussing treatment options on this podcast with host Dr. Narjust Duma are Dr. Alfredo Addeo, senior oncologist at Geneva Hospital in Geneva, Switzerland, and Dr. Hel...
Breakthrough Therapies - NRG1 with Dr. Laskin and Dr. Cadranel 28.12.2021 41:40
Dr. Jacques Cadranel, Head of Department Pulmonology and Thoracic Oncology, Assistance Publique Hôpitaux de Paris and Sorbonne University and Dr Janessa Laskin, Medical Oncologist at the Vancouver Cancer Centre in British Columbia, Canada join Lung Cancer Considered Host Dr. Narjust Duma to discuss current and promising breakthrough therapies in lung cancer.
LALCA 2021 Highlights With Luis E. Raez Christian Rolfo Lucia Viola 21.12.2021 37:10
Dr. Narjust Duma hosts a spirited Spanish-language edition of Lung Cancer Considered on the recently completed 2021 LALCA Schools of Thoracic Oncology meeting with Luis E. Raez, MD, Chief Scientific Officer & Medical Director Memorial Cancer Institute/Memorial Health Care System; Lucia Viola, MD, Interventional Pulmonologist, Head of Thoracic Oncology Service, Fundación Neumológica Colombiana and...
Virtual Tumor Board NSCLC - Anthony Kim And Patricia Rivera 07.12.2021 41:04
Lung Cancer Considered host Dr. Stephen Liu discusses a virtual tumor board with guests Dr. Anthony Kim, professor of clinical surgery and chief of thoracic surgery at The Keck School of Medicine at the University of Southern California and Dr. Patricia Rivera, professor of medicine at University of North Carolina and director of the UNC Lung Cancer Screening Initiative. The case involves a 45-yea...
IASLC Stars - Lillian Leigh, Erika Hlavacek, Caleb Egwuenu 01.12.2021 40:10
In this new episode of Lung Cancer Considered, podcast host Dr. Narjust Duma interviews three IASLC Patient Research Advocates who are part of the IASLC Supportive Training for Advocates on Research & Science (STARS) program: Caleb Egwuenu comes from Nigeria and participated in STARS for two years as a Patient Research Advocate: Erika Hlavacek, a Patient Research Advocate and founder of nonprofit...
Global Advocacy - Dr. Anne-Marie Baird 30.11.2021 29:06
Globally, lung cancer is the single most lethal cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to other cancer types. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses how global advocacy might play a role in addressing this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in...
Lung Cancer in Korea - Chul Kim, Young Tae Kim and Sun Min Lim 22.11.2021 50:04
In a special Korean-language Lung Cancer Considered episode, leading lung cancer specialists discuss the state of the disease in South Korea. Host Dr. Chul Kim, assistant professor of Medicine and Thoracic Medical Oncologist at Georgetown University, interviews Dr. Young Tae Kim, professor of the Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine and D...
Virtual Tumor Board NSCLC - Stephen Liu Erin Gillaspie And Shankar Siva 22.11.2021 41:23
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a virtual tumor board case focusing on a patient with stage III NSCLC. Guests are Dr. Erin Gillaspie, assistant professor of Thoracic Surgery at Vanderbilt University in Nashville, Tenn., and Dr. Shankar Siva, associate professor at the University of Melbourne, in Victoria, Australia.
Lung Cancer Advocate and Pro Golfer - Jason Day 09.11.2021 28:23
Professional Golfer Jason Day has known success in his career--he has been the top ranked PGA player and won the PGA Championship in 2015. Unfortunately, that year Jason’s mother Denning was diagnosed with state IV non-small-cell lung cancer, spurring Jason to become a passionate advocate for lung cancer research and treatment. Tune into this episode of Lung Cancer Considered to hear about how he...
White Ribbon Project - Heidi Nafman-Onda, Dr. Pierre Onda and Chris Draft 30.10.2021 54:15
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Heidi Nafman-Onda and her husband Dr. Pierre Onda, the founders of The White Ribbon project, and patient advocate/activist Chris Draft from the Chris Draft Family Foundation.
SCLC Research - Charles Rudin and Tripnara Sen 26.10.2021 26:28
This episode of Lung Cancer Considered looks ahead to the IASLC 2021 Hot Topic Meeting on Small Cell Lung Cancer, scheduled for Oct 29th and 30th 2021. Host Dr. Stephen Liu discusses the state of the SCLC research with Dr. Tripnara Sen, an Assistant Attending Biologist in the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Dr. Charles Rudin, the co-director of the Druckenmi...
Tumor Board Discussion: SCLC with Lauren Byers and Santiago Ponce Aix 19.10.2021 32:23
Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with small cell lung cancer. Guests include Dr. Lauren Byers, associate professor of Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Ponce Aix, from the Gustave Roussy in Paris, France.
ESMO Highlights - Solange Peters and Pasi Janne 14.10.2021 31:53
In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne, co-chair of ESMO 2021, discuss the recently concluded ESMO meeting and share the meeting’s most significant lung cancer research findings with podcast host Dr. Narjust Duma.
Politics and Medicine/Cancer with Nasser Hanna and Raja Flores 06.10.2021 48:50
The intersection of medicine and politics is fascinating and often controversial and contentious. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks to two physicians who have entered the political arena—Dr. Nasser Hanna, who ran in Indiana’s 5th Congressional District and Dr. Raja Flores, who is running for Mayor of New York City.
Peer to Peer: Issues, Strategies and Impact with Dr. Nathan Pennell 18.09.2021 42:28
In this episode of Lung Cancer Considered, Dr. Nathan Pennell, from the Cleveland Clinic, and Podcast host Dr. Narjust Duma, from Dana Farber Cancer Institute, share information about how lung cancer care has changed in the 14 years Dr. Pennell has been in practice.
2021 WCLC Highlights: Higgins, Harpole and Stinchcombe 15.09.2021 45:06
The IASLC 2021 World Conference on Lung Cancer co-chairs Dr. David Harpole, Dr. Kristin Higgins, Dr. Thomas Stinchcombe join Lung Cancer Considered Hosts Dr. Narjust Duma and Dr. Stephen Liu to cover highlights of the recently concluded virtual meeting. Tune in to hear these IASLC members discuss the most significant research developments from the conference.
Meet Our President and President Elect - Heather Wakelee and Paul Van Schil 07.09.2021 42:16
In this episode of Lung Cancer Considered , Dr. Heather Wakelee and Dr. Paul Van Schil join hosts Dr. Narjust Duma and Dr. Stephen Liu to discuss priorities and initiatives for IASLC in the 2021-22 year. Dr. Wakelee takes the reins as President of the IASLC this month during WCLC, the second woman to achieve this honor. Dr. Van Schil begins his term as President-Elect of the IASLC during WCLC, too...
Breakthrough Therapies - BRAF with Ibiayi Dagogo-Jack 31.08.2021 40:24
In this episode of Lung Cancer Considered, host Dr. Narjust Duma and Dr. Ibiayo Dagogo discuss BRAF mutated non-small cell lung cancer and some unique characteristics of patients with this mutation.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.